<DOC>
	<DOCNO>NCT02483195</DOCNO>
	<brief_summary>The investigator propose conduct head-to-head , randomize clinical trial compare effectiveness Minoxidil Spironolactone Finasteride treat postmenopausal female Androgenetic Alopecia ( AGA ) .</brief_summary>
	<brief_title>The Use 5mg Finasteride Versus 200mg Spironolactone Topical 5 % Minoxidil Treating Postmenopausal Female Androgenetic Alopecia</brief_title>
	<detailed_description>Participants diagnose AGA randomize one two treatment arm outline , take assign treatment total duration 12 month . Medications dispense nurse blind participant within treatment group . Global photograph assessment participant questionnaires 0 , 4 , 8 12 month primary mean determine improvement hair loss . Compare follow intervention treat postmenopausal female AGA : A ) Combination 5 % Minoxidil 200mg Spironolactone ( Combination Group ) B ) 5mg Finasteride placebo topical preparation ( Single Group )</detailed_description>
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<mesh_term>Finasteride</mesh_term>
	<mesh_term>Minoxidil</mesh_term>
	<criteria>female postmenopausal ( &gt; 60 year old total hysterectomy ) diagnose androgenetic alopecia chemical processing change hair product throughout study men premenopausal woman ( &lt; 60 without hysterectomy ) participants allergic study medication ( minoxidil , finasteride , spironolactone ) participant coexist form alopecia ( traction , alopecia areata , scar alopecia ) participant obstructive uropathy advance liver disease prior hair loss treatment within last 6 month hair loss chemotherapy medicationinduced alopecia Hair loss great 5 year , medical therapy unlikely much effect restore hair follicle inactive long period .</criteria>
	<gender>Female</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Hair loss</keyword>
	<keyword>Post Menopausal</keyword>
</DOC>